Ondrey Aaron — SEC Form 4 filings

SEC reporting owner CIK 1991078. 5 Form 4 filings on record with FilingPulse; latest filed 2025-07-08.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-01-23 to 2025-07-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ROCKET PHARMACEUTICALS, INC. (RCKT)Chief Financial Officer42 legs · 8,966 sh · $43,9034
Mirati Therapeutics, Inc. (MRTX)Chief Financial Officer16

Form 4 filings — Ondrey Aaron

FiledFormIssuerReported transactionsSource
2025-07-084ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 1,477 @ $2.88EDGAR
2025-04-084ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 7,489 @ $5.29EDGAR
2025-02-134ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 90,358 @ $0 · Grant/award (A): 134,642 (derivative) @ $0EDGAR
2024-04-034ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 46,781 @ $0 · Grant/award (A): 69,337 (derivative) @ $0EDGAR
2024-01-234Mirati Therapeutics, Inc. (MRTX)Disposition to issuer (D): 1,302 · Disposition to issuer (D): 21,138 · Disposition to issuer (D): 17,021 · Disposition to issuer (D): 6,817 (derivative) · Disposition to issuer (D): 5,027 (derivative) · Disposition to issuer (D): 11,993 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1991078 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →